SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-087912
Filing Date
2023-11-16
Accepted
2023-11-16 16:05:08
Documents
4
Period of Report
2023-11-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea188582-6k_nlspharma.htm 6-K 16371
2 FORM OF SHORT TERM LOAN AGREEMENT ea188582ex99-1_nlspharma.htm EX-99.1 28189
3 PRESS RELEASE TITLED: NLS PHARMACEUTICS ANNOUNCES SELECTION OF STRATEGIC PARTNER ea188582ex99-2_nlspharma.htm EX-99.2 13919
4 GRAPHIC ex99-2_001.jpg GRAPHIC 5371
  Complete submission text file 0001213900-23-087912.txt   67016
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 231414587
SIC: 2834 Pharmaceutical Preparations